Journal of Antimicrobial Chemotherapy (2002) 50, 265-269
© 2002 The British Society for Antimicrobial Chemotherapy
Influence of taxonomic status on the in vitro antimicrobial susceptibility of the Burkholderia cepacia complex
1 Department of Medical Microbiology, The University of Edinburgh, Teviot Place, Edinburgh EH8 9AG, UK; 2 Laboratorium voor Microbiologie, Universiteit Gent, K. L. Ledeganckstraat 35, B-9000 Gent, Belgium
Received 8 October 2001; returned 24 January 2002; revised 25 March 2002; accepted 6 June 2002
The Burkholderia cepacia complex is a diverse group of human pathogens that cause life-threatening lung infections in patients with cystic fibrosis or chronic granulomatous disease, and in patients requiring intensive care. Most previous antimicrobial susceptibility studies of these bacteria were performed before recent major revisions in the taxonomy of these bacteria. We determined the in vitro susceptibility of 65 B. cepacia complex isolates from clinical and environmental sources, representing six genomovars. Although intrinsic resistance is considered to be a common feature of the B. cepacia complex, MICs of individual antimicrobials varied widely and resistance was not exhibited by all members of the group.
* Corresponding author. Tel: +44-131-650-3164; Fax: +44-131-650-6653; E-mail: john.r.w.govan{at}ed.ac.uk
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  E. Peeters, H. J. Nelis, and T. Coenye In vitro activity of ceftazidime, ciprofloxacin, meropenem, minocycline, tobramycin and trimethoprim/sulfamethoxazole against planktonic and sessile Burkholderia cepacia complex bacteria J. Antimicrob. Chemother., October 1, 2009; 64(4): 801 - 809. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. S. Saldias and M. A. Valvano Interactions of Burkholderia cenocepacia and other Burkholderia cepacia complex bacteria with epithelial and phagocytic cells Microbiology, September 1, 2009; 155(9): 2809 - 2817. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Poirel, J.-M. Rodriguez-Martinez, P. Plesiat, and P. Nordmann Naturally Occurring Class A ss-Lactamases from the Burkholderia cepacia Complex Antimicrob. Agents Chemother., March 1, 2009; 53(3): 876 - 882. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Rose, A. Baldwin, C. G. Dowson, and E. Mahenthiralingam Biocide susceptibility of the Burkholderia cepacia complex J. Antimicrob. Chemother., March 1, 2009; 63(3): 502 - 510. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. T. G. Holden, H. M. B. Seth-Smith, L. C. Crossman, M. Sebaihia, S. D. Bentley, A. M. Cerdeno-Tarraga, N. R. Thomson, N. Bason, M. A. Quail, S. Sharp, et al. The Genome of Burkholderia cenocepacia J2315, an Epidemic Pathogen of Cystic Fibrosis Patients J. Bacteriol., January 1, 2009; 191(1): 261 - 277. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Zhou, Y. Chen, S. Tabibi, L. Alba, E. Garber, and L. Saiman Antimicrobial Susceptibility and Synergy Studies of Burkholderia cepacia Complex Isolated from Patients with Cystic Fibrosis Antimicrob. Agents Chemother., March 1, 2007; 51(3): 1085 - 1088. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. A. Loutet, R. S. Flannagan, C. Kooi, P. A. Sokol, and M. A. Valvano A Complete Lipopolysaccharide Inner Core Oligosaccharide Is Required for Resistance of Burkholderia cenocepacia to Antimicrobial Peptides and Bacterial Survival In Vivo J. Bacteriol., March 15, 2006; 188(6): 2073 - 2080. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. T. Kenna, H. Yesilkaya, K. J. Forbes, V. A. Barcus, P. Vandamme, and J. R. W. Govan Distribution and genomic location of active insertion sequences in the Burkholderia cepacia complex J. Med. Microbiol., January 1, 2006; 55(1): 1 - 10. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E Mahenthiralingam and P Vandamme Taxonomy and pathogenesis of the Burkholderia cepacia complex Chronic Respiratory Disease, October 1, 2005; 2(4): 209 - 217. [Abstract] [PDF]
|
|
|
|
|
|
X. Ortega, T. A. Hunt, S. Loutet, A. D. Vinion-Dubiel, A. Datta, B. Choudhury, J. B. Goldberg, R. Carlson, and M. A. Valvano Reconstitution of O-Specific Lipopolysaccharide Expression in Burkholderia cenocepacia Strain J2315, Which Is Associated with Transmissible Infections in Patients with Cystic Fibrosis J. Bacteriol., February 15, 2005; 187(4): 1324 - 1333. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. A. Hunt, C. Kooi, P. A. Sokol, and M. A. Valvano Identification of Burkholderia cenocepacia Genes Required for Bacterial Survival In Vivo Infect. Immun., July 1, 2004; 72(7): 4010 - 4022. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. De Soyza, C. D. Ellis, C. M. A. Khan, P. A. Corris, and R. D. de Hormaeche Burkholderia cenocepacia Lipopolysaccharide, Lipid A, and Proinflammatory Activity Am. J. Respir. Crit. Care Med., July 1, 2004; 170(1): 70 - 77. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. G. Veloira, P. Domenico, J. J. LiPuma, J. M. Davis, E. Gurzenda, and J. A. Kazzaz In vitro activity and synergy of bismuth thiols and tobramycin against Burkholderia cepacia complex J. Antimicrob. Chemother., December 1, 2003; 52(6): 915 - 919. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Langley, D. T. Kenna, P. Vandamme, R. Ure, and J. R. W. Govan Lysogeny and bacteriophage host range within the Burkholderia cepacia complex J. Med. Microbiol., June 1, 2003; 52(6): 483 - 490. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U. S. Sajjan, H. Xie, M. D. Lefebre, M. A. Valvano, and J. F. Forstner Identification and molecular analysis of cable pilus biosynthesis genes in Burkholderia cepacia Microbiology, April 1, 2003; 149(4): 961 - 971. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. D. Lefebre and M. A. Valvano Construction and Evaluation of Plasmid Vectors Optimized for Constitutive and Regulated Gene Expression in Burkholderia cepacia Complex Isolates Appl. Envir. Microbiol., December 1, 2002; 68(12): 5956 - 5964. [Abstract] [Full Text] [PDF]
|
|